Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Alphamab Co Ltd (9966 HK)
Watchlist
144
Analysis
Health Care
•
China
Alphamab Oncology produces and sells drugs. The Company manufactures and sells tumor immunobiology macromolecular targeted drug and other products. Alphamab Oncology provides services worldwide.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Quantitative Analysis
•
14 May 2023 10:15
Hong Kong Connect Flows (May 12th): CNOOC, BOC, Petrochina, China Shenhua Energy, CCB, HKEX, SMIC
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Cnooc, Bank Of China, Petrochina, China Shenhua Energy,...
Ke Yan, CFA, FRM
Follow
484 Views
Share
bullish
•
Quantitative Analysis
•
01 May 2023 12:43
Hong Kong Connect Flows (Apr 28th): Meituan, China Construction Bank
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for Meituan, China Construction Bank.
Ke Yan, CFA, FRM
Follow
471 Views
Share
bullish
•
Quantitative Analysis
•
23 Apr 2023 10:10
Hong Kong Connect Flows (Apr 21st): China Mobile, Anta, SMIC, Tencent, CCB, Sensetime
We analyzed the Hong Kong Connect Scheme for last week and highlight flows for China Mobile, Anta, SMIC, Tencent, CCB, Sensetime.
Ke Yan, CFA, FRM
Follow
534 Views
Share
bullish
•
Quantitative Analysis
•
08 Mar 2023 14:33
Hong Kong Connect Flows Monthly: First Monthly Outflows in 12 Months
We analyzed the Hong Kong Connect Scheme for February and highlight flows for China Mobile, GWM, Sensetime, Tencent, HKEx, CCB, Meituan, BYD.
Ke Yan, CFA, FRM
Follow
527 Views
Share
bearish
•
Quantitative Analysis
•
26 Feb 2023 10:15
Hong Kong Connect Flows (Feb 24th): China Mobile, Tencent, Byd, CCB
We analyzed southbound Hong Kong connect flows in the past week and highlight flows for China Mobile, Tencent, Byd, China Construction Bank.
Ke Yan, CFA, FRM
Follow
521 Views
Share
First
Previous
13
14
15
16
17
18
19
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x